Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan F Hastings

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|April 23, 2020
Applications of personalised signalling network models in precision oncologyJordan F Hastings, Yolande E I O'Donnell, Dirk Fey, et al.
Frontiers in Cell and Developmental Biology|September 7, 2016
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilySean P Kennedy, Jordan F Hastings, Jeremy Z R Han, et al.
Frontiers in Cell and Developmental Biology|May 28, 2020
Breathing New Life into the Mechanisms of Platinum Resistance in Lung AdenocarcinomaAlvaro Gonzalez-Rajal, Jordan F Hastings, D Neil Watkins, et al.
British Journal of Pharmacology|March 7, 2018
The extracellular matrix as a key regulator of intracellular signalling networksJordan F Hastings, Joanna N Skhinas, Dirk Fey, et al.
Journal of Personalized Medicine|June 2, 2021
Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug ResponseJeremy Z R Han, Jordan F Hastings, Monica Phimmachanh, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)Jordan F Hastings, Jeremy Z R Han, Robert F Shearer, et al.
Science Signaling|July 14, 2016
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimersDavid R Croucher, Mary Iconomou, Jordan F Hastings, et al.
Science Signaling|December 24, 2015
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patientsDirk Fey, Melinda Halasz, Daniel Dreidax, et al.
Elife|June 10, 2020
Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinomaJordan F Hastings, Alvaro Gonzalez Rajal, Sharissa L Latham, et al.
Elife|May 13, 2021
A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinomaAlvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|April 23, 2020
Applications of personalised signalling network models in precision oncologyJordan F Hastings, Yolande E I O'Donnell, Dirk Fey, et al.
Frontiers in Cell and Developmental Biology|September 7, 2016
The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor FamilySean P Kennedy, Jordan F Hastings, Jeremy Z R Han, et al.
Frontiers in Cell and Developmental Biology|May 28, 2020
Breathing New Life into the Mechanisms of Platinum Resistance in Lung AdenocarcinomaAlvaro Gonzalez-Rajal, Jordan F Hastings, D Neil Watkins, et al.
British Journal of Pharmacology|March 7, 2018
The extracellular matrix as a key regulator of intracellular signalling networksJordan F Hastings, Joanna N Skhinas, Dirk Fey, et al.
Journal of Personalized Medicine|June 2, 2021
Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug ResponseJeremy Z R Han, Jordan F Hastings, Monica Phimmachanh, et al.
Journal of Visualized Experiments : Jove|July 10, 2018
Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)Jordan F Hastings, Jeremy Z R Han, Robert F Shearer, et al.
Science Signaling|July 14, 2016
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimersDavid R Croucher, Mary Iconomou, Jordan F Hastings, et al.
Science Signaling|December 24, 2015
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patientsDirk Fey, Melinda Halasz, Daniel Dreidax, et al.
Elife|June 10, 2020
Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinomaJordan F Hastings, Alvaro Gonzalez Rajal, Sharissa L Latham, et al.
Elife|May 13, 2021
A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinomaAlvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, et al.
Pageof 2